{"altmetric_id":4265948,"counts":{"readers":{"mendeley":17,"citeulike":0,"connotea":0},"total":{"posts_count":8},"twitter":{"unique_users_count":6,"unique_users":["FactamFarmacia","emiliomonteb","Manzanera_j","GuillaumeGory","pmctrawler","manuelj9"],"posts_count":7},"peer_reviews":{"unique_users_count":1,"unique_users":["pubpeer"],"posts_count":1}},"selected_quotes":["Comment on Taburet AM (2015): Pharmacokinetics of Raltegravir in HIV-Infected Patients on Rifampicin-Based Antit","double dose raltegravir + rifampicin\/ INH.... but what about dolutegravir? @TimLaheyMD #IDWeek2015 @IDSAInfo"],"citation":{"abstract":"\u2003Rifampicin induces UGT1A1, an enzyme involved in raltegravir elimination, thereby potentially lowering raltegravir exposure. We examined the pharmacokinetics of raltegravir in HIV-infected patients on rifampicin-based antitubercular therapy in the ANRS 12 180 Reflate TB trial.\n\u2003Patients started raltegravir in combination with TDF and 3TC after initiation of rifampicin (10 mg\/kg\/d). In arm 1 (n=21) they received 400 mg BID raltegravir, while in arm 2 (n=16) they received 800 mg BID raltegravir initially then 400 mg BID four weeks after rifampicin discontinuation. Pharmacokinetic sampling was performed over 12-hour periods, 4 weeks after initiation of raltegravir together with rifampicin (period 1), 4 weeks after rifampicin discontinuation (period 2), and after the raltegravir dose reduction in arm 2 (period 3).\n\u2003In arm 1, the geometric mean ratio (GMR) between period 1 and period 2 was 0.94 (90% confidence interval (CI): 0.64 to 1.37) for the 12-hour area under the time-concentration curve (AUC0-12), and 0.69 (90% CI: 0.42-1.13) for the concentration at 12 hours (C12). In arm 2, the corresponding GMRs were 0.75 (90% CI: 0.48 to 1.17) and 1.10 (90% CI: 0.61-2.00) for period 1 versus period 2, and 1.10 (90% CI: 0.78 to 1.55) and 1.68 (90% CI: 0.88-3.23) for period 1 versus period 3.\n\u2003The double dose of raltegravir over compensated for rifampicin induction, but the standard dose was associated with only small decreases in AUC0-12 and C12 during rifampicin co-administration, warranting further evaluation in patients with HIV\/TB coinfection.","altmetric_jid":"4f6fa4ea3cf058f61000255e","authors":["Taburet, Anne-Marie","Sauvageon, H\u00e9l\u00e8ne","Grinsztejn, Beatriz","Assuied, Alex","Veloso, Valdilea","Pilotto, Jos\u00e9 Henrique","De Castro, Nathalie","Grondin, Carine","Fagard, Catherine","Molina, Jean-Michel","Anne-Marie Taburet","H\u00e9l\u00e8ne Sauvageon","Beatriz Grinsztejn","Alex Assuied","Valdilea Veloso","Jos\u00e9 Henrique Pilotto","Nathalie De Castro","Carine Grondin","Catherine Fagard","Jean-Michel Molina"],"doi":"10.1093\/cid\/civ477","endpage":"1335","first_seen_on":"2015-07-11T22:33:34+00:00","funders":["niehs"],"issns":["1537-6591","1058-4838"],"issue":"8","journal":"Clinical Infectious Diseases","last_mentioned_on":1483420310,"links":["http:\/\/cid.oxfordjournals.org\/content\/early\/2015\/07\/08\/cid.civ477.long","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26105170","http:\/\/cid.oxfordjournals.org\/content\/early\/2015\/06\/22\/cid.civ477.long","https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26105170","http:\/\/dx.doi.org\/10.1093\/cid\/civ477"],"pdf_url":"http:\/\/cid.oxfordjournals.org\/content\/61\/8\/1328.full.pdf","pmid":"26105170","pubdate":"2015-10-15T00:00:00+00:00","publisher_subjects":[{"name":"Biological Sciences","scheme":"era"},{"name":"Medical And Health Sciences","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"startpage":"1328","subjects":["communicablediseases"],"title":"Pharmacokinetics of Raltegravir in HIV-infected Patients on Rifampicin-Based Antitubercular Therapy.","type":"article","volume":"61","mendeley_url":"http:\/\/www.mendeley.com\/research\/pharmacokinetics-raltegravir-hivinfected-patients-rifampicinbased-antitubercular-therapy"},"altmetric_score":{"score":4.2,"score_history":{"1y":1.75,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":4.2},"context_for_score":{"all":{"total_number_of_other_articles":7976486,"mean":6.7343932358615,"rank":1657737,"this_scored_higher_than_pct":79,"this_scored_higher_than":6308180,"rank_type":"exact","sample_size":7976486,"percentile":79},"similar_age_3m":{"total_number_of_other_articles":226148,"mean":8.2000079505809,"rank":56199,"this_scored_higher_than_pct":74,"this_scored_higher_than":169481,"rank_type":"exact","sample_size":226148,"percentile":74},"this_journal":{"total_number_of_other_articles":7736,"mean":8.9259519069166,"rank":2559,"this_scored_higher_than_pct":66,"this_scored_higher_than":5168,"rank_type":"exact","sample_size":7736,"percentile":66},"similar_age_this_journal_3m":{"total_number_of_other_articles":147,"mean":12.02998630137,"rank":79,"this_scored_higher_than_pct":46,"this_scored_higher_than":68,"rank_type":"exact","sample_size":147,"percentile":46}}},"demographics":{"poster_types":{"member_of_the_public":6},"users":{"twitter":{"cohorts":{"Members of the public":5,"Practitioners (doctors, other healthcare professionals)":1}},"mendeley":{"by_status":{"Librarian":2,"Researcher":2,"Student  > Ph. D. Student":3,"Student  > Postgraduate":1,"Other":3,"Student  > Master":4,"Student  > Bachelor":1,"Professor":1},"by_discipline":{"Materials Science":1,"Medicine and Dentistry":9,"Agricultural and Biological Sciences":1,"Biochemistry, Genetics and Molecular Biology":2,"Unspecified":2,"Pharmacology, Toxicology and Pharmaceutical Science":2}}},"geo":{"twitter":{"ES":3,"VE":1}}},"posts":{"twitter":[{"url":"https:\/\/twitter.com\/FactamFarmacia\/status\/613619233826672640","license":"datasift","rt":["emiliomonteb"],"citation_ids":[4265948],"posted_on":"2015-06-24T08:06:40+00:00","author":{"name":"Factam Farmacia","url":"http:\/\/www.factam.com","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000034815217\/7184c9698b0ddda76b608141822b37e6_normal.jpeg","description":"Estudios de Mercado: Necesidades, Demandas, Satisfacci\u00f3n y Perfil de Clientes. Estudios Farmacoecon\u00f3micos. Creaci\u00f3n Tienda On Line, Displays, Apps,","id_on_source":"FactamFarmacia","tweeter_id":"1541322673","geo":{"lt":40.42526,"ln":-3.69063,"country":"ES"},"followers":1741},"tweet_id":"613619233826672640"},{"url":"https:\/\/twitter.com\/emiliomonteb\/status\/613614416932794368","license":"datasift","citation_ids":[4265948],"posted_on":"2015-06-24T07:47:32+00:00","author":{"name":"Emilio Monte","url":"https:\/\/www.linkedin.com\/in\/emilio-monte-boquet-67032624\/","image":"https:\/\/pbs.twimg.com\/profile_images\/898548741422153728\/en1Mia9R_normal.jpg","description":"#Farmacia #HospitalLaFe #HospitalPharmacy PharmD PhD #eSalud #eHealth #Sherpas20 @ufpelafe @eDruida_","id_on_source":"emiliomonteb","tweeter_id":"51391835","geo":{"lt":39.5,"ln":-0.75,"country":"ES"},"followers":3638},"tweet_id":"613614416932794368"},{"url":"https:\/\/twitter.com\/Manzanera_j\/status\/613644024671543296","license":"datasift","rt":["emiliomonteb"],"citation_ids":[4265948],"posted_on":"2015-06-24T09:45:11+00:00","author":{"name":"Jaime Manzanera","image":"https:\/\/pbs.twimg.com\/profile_images\/898804536093151232\/I2hnACr8_normal.jpg","description":"Mente inquieta, bioquimico, bio-nano-tecn\u00f3logo, comprometido, curioso, Geek, trabajo en #farma y me apasiona la #innovacion! mi opini\u00f3n es m\u00eda...","id_on_source":"Manzanera_j","tweeter_id":"401268929","geo":{"lt":41.38879,"ln":2.15899,"country":"ES"},"followers":502},"tweet_id":"613644024671543296"},{"url":"https:\/\/twitter.com\/GuillaumeGory\/status\/615614699774836737","license":"datasift","rt":["emiliomonteb"],"citation_ids":[4265948],"posted_on":"2015-06-29T20:15:56+00:00","author":{"name":"Guillaume GORY","image":"http:\/\/pbs.twimg.com\/profile_images\/593131822294409218\/c7TtHJjW_normal.jpg","description":"Pharmacien - Industrie Pharmaceutique","id_on_source":"GuillaumeGory","tweeter_id":"2765002073","followers":2},"tweet_id":"615614699774836737"},{"url":"https:\/\/twitter.com\/emiliomonteb\/status\/619868421275131904","license":"datasift","citation_ids":[4265948],"posted_on":"2015-07-11T13:58:42+00:00","author":{"name":"Emilio Monte","url":"https:\/\/www.linkedin.com\/in\/emilio-monte-boquet-67032624\/","image":"https:\/\/pbs.twimg.com\/profile_images\/898548741422153728\/en1Mia9R_normal.jpg","description":"#Farmacia #HospitalLaFe #HospitalPharmacy PharmD PhD #eSalud #eHealth #Sherpas20 @ufpelafe @eDruida_","id_on_source":"emiliomonteb","tweeter_id":"51391835","geo":{"lt":39.5,"ln":-0.75,"country":"ES"},"followers":3638},"tweet_id":"619868421275131904"},{"url":"http:\/\/twitter.com\/pmctrawler\/statuses\/768203919801454592","license":"gnip","citation_ids":[4265948],"posted_on":"2016-08-23T21:51:01+00:00","author":{"name":"PubMed Commons Trawl","url":"https:\/\/gist.github.com\/anonymous\/7167231","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000649264479\/999a1106baee29a2410d5f41eaa8040e_normal.jpeg","description":"Tweets when articles get their first Commons comment. Not a service of or sanctioned by NIH. Experimental; accuracy not guaranteed!","id_on_source":"pmctrawler","tweeter_id":"2156389052","geo":{"lt":null,"ln":null},"followers":190},"tweet_id":"768203919801454592"},{"url":"http:\/\/twitter.com\/manuelj9\/statuses\/783978040418271232","license":"gnip","citation_ids":[4265948],"posted_on":"2016-10-06T10:31:45+00:00","author":{"name":"Me. Manuel Montilva","image":"https:\/\/pbs.twimg.com\/profile_images\/2125735446\/IMG-20120413-00046_normal.jpg","description":"Sub Director Hospital Central Dr. Urquinaona. Secretaria de Salud Zulia","id_on_source":"manuelj9","tweeter_id":"255949944","geo":{"lt":10.63167,"ln":-71.64056,"country":"VE"},"followers":548},"tweet_id":"783978040418271232"}],"peer_reviews":[{"url":"https:\/\/pubpeer.com\/publications\/FA8529F6C3BCAAFCE4A735A42EADAC#fb114548","license":"public","citation_ids":[4265948],"posted_on":"2017-01-03T05:11:50+00:00","summary":"Ben Goldacre | Aug 23 2016 13:03 ESTThis trial has the wrong trial registry ID associated with it on PubMed: both in the XML on PubMed, and in the originating journal article...","author":{"id_on_source":"Comment from PubMed Commons"},"pr_id":"pubpeer","publons_quality_score":null,"publons_significance_score":null,"publons_review_type":null,"publons_weighted_average":null,"publons_article_url":null,"pubpeer_publication_url":"https:\/\/pubpeer.com\/publications\/FA8529F6C3BCAAFCE4A735A42EADAC"}]}}